Toxicokinetics of Pirfenidone in Dogs Following Inhalation in a Nebulized Aerosol Formulation | BioAgilytix

Purpose

To assess the toxicokinetics (TK) exposure of pirfenidone (AP01) during a 28-day oronasal dog inhalation toxicity study.

Download Poster

Comparison of the Pharmacokinetics of Four Different Dose- Frequency Combinations of AMZ001 (Diclofenac Gel 3.06%) with Voltaren^® (Diclofenac Gel 1%) in Healthy Subjects in a Phase 1 Study

Potency Assay Development for Gene Therapy Products – Approaches and Points to Consider in Data Processing